Education
About Us
Working with TipRanks
Follow Us
Citius Pharmaceuticals (CTXR)
NASDAQ:CTXR
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -214.25K | $ -209.61K | $ -194.32K | $ -179.68K | $ -164.87K |
| Operating Income | $ -38.53M | $ -42.00M | $ -36.73M | $ -33.32M | $ -23.53M |
| EBITDA | $ -38.20M | $ -38.64M | $ -31.77M | $ -32.88M | $ -22.88M |
| Net Income | $ -37.43M | $ -39.14M | $ -32.54M | $ -33.64M | $ -23.13M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 4.25M | $ 3.25M | $ 26.48M | $ 41.71M | $ 70.07M |
| Total Assets | $ 130.94M | $ 116.65M | $ 103.61M | $ 114.00M | $ 142.43M |
| Total Debt | $ 813.27K | $ 262.87K | $ 481.25K | $ 678.23K | $ 855.47K |
| Net Debt | $ -3.44M | $ -2.99M | $ -26.00M | $ -41.03M | $ -69.22M |
| Total Liabilities | $ 53.41M | $ 42.55M | $ 12.18M | $ 10.57M | $ 9.65M |
| Stockholders' Equity | $ 67.55M | $ 70.08M | $ 90.83M | $ 102.83M | $ 132.18M |
| Cash Flow | |||||
| Free Cash Flow | $ -26.55M | $ -28.20M | $ -29.06M | $ -28.36M | $ -64.26M |
| Operating Cash Flow | $ -26.55M | $ -28.20M | $ -29.06M | $ -28.36M | $ -24.25M |
| Investing Cash Flow | $ -5.75M | $ -5.00M | $ 0.00 | $ 0.00 | $ -40.01M |
| Financing Cash Flow | $ 33.30M | $ 9.97M | $ 13.83M | $ 0.00 | $ 120.47M |
Citius Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.